Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia
Authors
Keywords
-
Journal
eLife
Volume 4, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2015-08-29
DOI
10.7554/elife.08997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BET bromodomain proteins are required for glioblastoma cell proliferation
- (2014) Chiara Pastori et al. Epigenetics
- The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers
- (2014) Jun Long et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells
- (2014) Stuart J. Gallagher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An open investigation of the reproducibility of cancer biology research
- (2014) Timothy M Errington et al. eLife
- Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
- (2013) A. Chaidos et al. BLOOD
- Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
- (2013) M A Dawson et al. LEUKEMIA
- BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms
- (2013) B S Wyspiańska et al. LEUKEMIA
- Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
- (2013) B Tolani et al. ONCOGENE
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- The super elongation complex (SEC) and MLL in development and disease
- (2011) E. Smith et al. GENES & DEVELOPMENT
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mixed lineage leukemia: roles in human malignancies and potential therapy
- (2010) Rolf Marschalek FEBS Journal
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- The molecular biology of mixed lineage leukemia
- (2009) R. K. Slany HAEMATOLOGICA
- New insights to the MLL recombinome of acute leukemias
- (2009) C Meyer et al. LEUKEMIA
- Brd4 Marks Select Genes on Mitotic Chromatin and Directs Postmitotic Transcription
- (2009) Anup Dey et al. MOLECULAR BIOLOGY OF THE CELL
- Misguided Transcriptional Elongation Causes Mixed Lineage Leukemia
- (2009) Dorothee Mueller et al. PLOS BIOLOGY
- The Double Bromodomain Proteins Brd2 and Brd3 Couple Histone Acetylation to Transcription
- (2008) Gary LeRoy et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation